Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury

Background: Nephrotoxic medication (NTM) avoidance may prevent further kidney damage in children with acute kidney injury (AKI). We compared outpatient NTM prescriptions in children with or without AKI during pediatric intensive care (PICU) hospitalization. We hypothesize that children with AKI are...

Full description

Bibliographic Details
Main Authors: Claire Lefebvre, Marc Dorais, Erin Hessey, Michael Zappitelli
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/8/11/948
_version_ 1797510741632221184
author Claire Lefebvre
Marc Dorais
Erin Hessey
Michael Zappitelli
author_facet Claire Lefebvre
Marc Dorais
Erin Hessey
Michael Zappitelli
author_sort Claire Lefebvre
collection DOAJ
description Background: Nephrotoxic medication (NTM) avoidance may prevent further kidney damage in children with acute kidney injury (AKI). We compared outpatient NTM prescriptions in children with or without AKI during pediatric intensive care (PICU) hospitalization. We hypothesize that children with AKI are prescribed NTMs at the same rate as those without it. Methods: This was a retrospective administrative data study of children <18 years, admitted to two PICUs in Montreal, Canada, from 2003 to 2005, with ≥30 days of provincial drug coverage. We evaluated the presence of ≥3 outpatient NTM prescriptions during the first year and 5 years after PICU discharge. Results: Of 970 children, 23% had PICU AKI. In the 1st–5th years after discharge, 18% AKI vs. 10% non-AKI and 13% AKI vs. 4% non-AKI patients received ≥3 NTM prescriptions, respectively. There was no association between PICU AKI and prescription of ≥3 NTMs during the first year (adjusted RR 1.02 [95% CI 0.95–1.10]) nor in the first 5 years post-discharge (adjusted RR 1.04 [95%CI 0.96–1.12]). Conclusions: By offering a better understanding of the current state of outpatient NTM prescription to children with AKI, our study is a step toward considering strategies such as knowledge translation interventions for decreasing NTM exposure and improving outcomes in children with AKI.
first_indexed 2024-03-10T05:36:31Z
format Article
id doaj.art-9839368224a041f19ac95b47638f2394
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-10T05:36:31Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-9839368224a041f19ac95b47638f23942023-11-22T22:54:18ZengMDPI AGChildren2227-90672021-10-0181194810.3390/children8110948Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney InjuryClaire Lefebvre0Marc Dorais1Erin Hessey2Michael Zappitelli3Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC H3T 1C5, CanadaStatSciences Inc., Notre-Dame-de-l’Île-Perrot, QC J7V 7P2, CanadaFaculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, CanadaDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC H3A 1A2, CanadaBackground: Nephrotoxic medication (NTM) avoidance may prevent further kidney damage in children with acute kidney injury (AKI). We compared outpatient NTM prescriptions in children with or without AKI during pediatric intensive care (PICU) hospitalization. We hypothesize that children with AKI are prescribed NTMs at the same rate as those without it. Methods: This was a retrospective administrative data study of children <18 years, admitted to two PICUs in Montreal, Canada, from 2003 to 2005, with ≥30 days of provincial drug coverage. We evaluated the presence of ≥3 outpatient NTM prescriptions during the first year and 5 years after PICU discharge. Results: Of 970 children, 23% had PICU AKI. In the 1st–5th years after discharge, 18% AKI vs. 10% non-AKI and 13% AKI vs. 4% non-AKI patients received ≥3 NTM prescriptions, respectively. There was no association between PICU AKI and prescription of ≥3 NTMs during the first year (adjusted RR 1.02 [95% CI 0.95–1.10]) nor in the first 5 years post-discharge (adjusted RR 1.04 [95%CI 0.96–1.12]). Conclusions: By offering a better understanding of the current state of outpatient NTM prescription to children with AKI, our study is a step toward considering strategies such as knowledge translation interventions for decreasing NTM exposure and improving outcomes in children with AKI.https://www.mdpi.com/2227-9067/8/11/948pediatricsrenalkidney diseasenephrotoxicityprescription patterns
spellingShingle Claire Lefebvre
Marc Dorais
Erin Hessey
Michael Zappitelli
Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
Children
pediatrics
renal
kidney disease
nephrotoxicity
prescription patterns
title Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
title_full Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
title_fullStr Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
title_full_unstemmed Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
title_short Outpatient Nephrotoxic Medication Prescription after Pediatric Intensive Care Acute Kidney Injury
title_sort outpatient nephrotoxic medication prescription after pediatric intensive care acute kidney injury
topic pediatrics
renal
kidney disease
nephrotoxicity
prescription patterns
url https://www.mdpi.com/2227-9067/8/11/948
work_keys_str_mv AT clairelefebvre outpatientnephrotoxicmedicationprescriptionafterpediatricintensivecareacutekidneyinjury
AT marcdorais outpatientnephrotoxicmedicationprescriptionafterpediatricintensivecareacutekidneyinjury
AT erinhessey outpatientnephrotoxicmedicationprescriptionafterpediatricintensivecareacutekidneyinjury
AT michaelzappitelli outpatientnephrotoxicmedicationprescriptionafterpediatricintensivecareacutekidneyinjury